This paper introduces the reader to the field of liquid biopsies and cell-free nucleic acids,
focusing on circulating tumor DNA (ctDNA) in breast cancer (BC). BC is the most common …

Non-small cell lung cancer (NSCLC) is the most prevalent histological type of lung cancer
and the leading cause of death globally. Patients with NSCLC have a poor prognosis for …

Now, genomics forms the core of the precision medicine concept. Comprehensive
investigations of tumor genomes have made it possible to characterize tumors at the …

Bronchoscopy is a frequently used initial diagnostic procedure for patients with suspected
lung cancer (LC). Cytological examinations of bronchial washing (BW) samples obtained …

Background While the widespread use of endoscopic submucosal dissection (ESD) has
significantly reduced the incidence of early esophageal cancer (ESCA), the limited ability of …

Abstract Background Circulating tumor cells (CTCs) play a crucial role in the early diagnosis
and prognosis of lung cancer. Identification of a more suitable sample source could be a …

Screening for lung cancer has been seeing new developments, with a focus on emerging
technologies and the integration of artificial intelligence. While low-dose computed …

The clinical use of cell-free DNA (cfDNA) methylation in managing lung cancer depends on
its ability to differentiate between malignant and healthy cells, assign methylation changes to …